European shares slip for fifth day on weakness in banks, consumer staples



(For a Reuters live blog on U.S., UK and European stock markets, click

or type LIVE/ in a news window.)

*

STOXX 600 falls for fifth straight day, off 0.2%

*

British American Tobacco warns of higher finance costs

*

Hopes run high for Credit Suisse multibillion cash call

By Amruta Khandekar and Bansari Mayur Kamdar

Dec 8 (Reuters) - European shares fell for the fifth straight session on Thursday, bogged down by weakness in banks and consumer staples amid growing fears of an impending recession.

The region-wide STOXX 600 .STOXX slipped 0.2%, with investors jittery ahead of a slew of interest rate decisions from major central banks, including from the U.S. Federal Reserve and the European Central Bank next week.

"We're in a wait-and-see mode at the moment. Next week is a huge week for all markets and that is really going to set the tone between now and year-end," said Hugh Gimber, global market strategist at J.P. Morgan Asset Management in London.

"There is a little bit too much excitement in the market at the moment as to how quickly the central banks are going to be able to slow the pace of tightening because inflation is still too high," he said. "That's very very clear in both the eurozone and the UK."

European Central Bank President Christine Lagarde is also due to speak at an event later in the day.

Financials were a big drag on the pan-European STOXX 600 index, with banks .SX7E falling for their fourth consecutive session.

The London Stock Exchange Group plc LSEG.L dropped 6.4% as UBS cut its rating and price target.

Consumer staples stocks also fell, with British American Tobacco BATS.L down 3.1% after the tobacco firm said it expects net finance costs to top 1.6 billion pounds ($1.95 billion) in FY22 due to rising interest rates globally and a strong dollar.

However, China's loosening of its strict COVID-19 curbs boosted sectors such as energy .SXEP and miners .SXPP , which rose 0.2% and 1.2%, respectively, tracking oil and metal prices higher.

Also limiting losses, technology stocks .SX8P snapped their four-day losing streak, boosted by a recovery in semiconductor stocks.

Credit Suisse CSGN.S headed into the final stage of a 4 billion Swiss francs ($4.25 billion) cash call that it hopes will allow an overhaul to draw a line under years of scandals. Shares of the Swiss bank rose 3.2%. ($1 = 0.8211 pounds)
Reporting by Amruta Khandekar and Bansari Mayur Kamdar in Bengaluru Editing by Janane Venkatraman and Matthew Lewis

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

We are using cookies to give you the best experience on our website. Read more or change your cookie settings.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.